bioRxivNeurosciencePreprint
α-Synuclein Strain Dynamics Predict Cognitive Transitions in Parkinson's Disease
Kundlik GadhaveiD, Ning WangiD, Kyungdo KimiD, Enquan XuiD, Xiaodi ZhangiD, Hanyu LiiD, Jacob DeyelliD, Jun YangiD, Anthony WangiD, Youngjae ChaiD, Ramhari KumbhariD, Haiqing LiuiD, Lili Niu, Rong CheniD, Shu Zhang, Catherine C. Bakker, Lingtao JiniD, Yajie LiangiD, Mingyao YingiD, Brenna CholertoniD, Vadim Zipunnikov, Nikolay BliznyukiD, Joseph F. QuinniD, Kathryn A. ChungiD, Amie L. Hiller, , Xiaobo MaoiD
- Citations
- 3
Abstract
-Synuclein (-syn) strains can serve as discriminators between Parkinsons disease (PD) and related -synucleinopathies. The relationship between -syn strain dynamics and clinical performance as patients transition from normal cognition (NC) to cognitive impairment (CI) is not known. Here, we show that the biophysical properties and neurotoxicity of -syn strains change as PD cognitive status transitions from NC to mild cognitive impairment (PD-MCI) and dementia (PD-D). Both cross-sectional and longitudinal analyses reveal distinct -syn strains in PD patients correlating to their level of cognitive impairment. Machine learning (ML) was employed to achieve high classification accuracy. The combination of thioflavin T (ThT) maximal fluorescence intensity (mfi), max slope of rise curve (forming rate), lag time (tlag), 20% time (t20), and half-time (t50), dynamic light scattering (DLS) (peak number, [1/2] peak size, [1/2] peak intensity) and neurotoxicity together with demographic variables for model training yielded superior performance (89[~]99% accuracy in the 4- and 2- classification schema) compared to individual features alone in classifying cognitive status. For the longitudinal study, DLS peak number emerged as the strongest predictor of cognitive transition (HR = 0.12, P = 0.002), with the optimal predictive model combining DLS peak number, sex, education, DLS peak 1 size, and DLS peak 2 polydispersity achieving high accuracy (C-index of [~]93%). This study presents evidence that individuals with PD have different -syn strains correlating to their cognitive status and highlights the potential of -syn strain dynamics to guide future diagnosis, management, and stratification of PD patients. One Sentence SummaryDistinct features of -syn strains change with cognitive decline in Parkinsons disease and AI-based analysis incorporating these combined characteristics serves as a powerful tool for PD clinical stratification.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- approach: machine learning (classical)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies
George T. Kannarkat, Rebecca Zack, … Alice S. Chen‐Plotkin·bioRxiv·May 7, 2024
- Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and Dementia with Lewy bodies
Irene Frigerio, Maud M. A. Bouwman, … Laura E. Jonkman·Acta Neuropathologica CommunicationsPeer-reviewed·Jan 3, 2024
- Cryo-EM structures of α-synuclein filaments from Parkinson's disease and dementia with Lewy bodies
Yang Yang, Yang Shi, … Michel Goedert·bioRxiv·Jul 12, 2022
- Transcriptional Dysregulation in the Hippocampus of a murine model for Parkinson's Disease Cognition Impairment is Driven by Sex, Age, and Alpha-synuclein overexpression
Alessia Sciortino, Thomas Hentrich, … Manuel Buttini·bioRxiv·Jul 18, 2025
- Distinct alpha-synuclein strains derived from Parkinson's disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model
Anupam Raina, Wen Wang, … Shu G. Chen·Journal of Biological ChemistryPeer-reviewed·Dec 8, 2025
- Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson's disease
Chen‐Pei Lin, Lydian Knoop, … Laura E. Jonkman·Movement DisordersPeer-reviewed·Jun 22, 2023